234 related articles for article (PubMed ID: 35940203)
1. DOCK2 is involved in the host genetics and biology of severe COVID-19.
Namkoong H; Edahiro R; Takano T; Nishihara H; Shirai Y; Sonehara K; Tanaka H; Azekawa S; Mikami Y; Lee H; Hasegawa T; Okudela K; Okuzaki D; Motooka D; Kanai M; Naito T; Yamamoto K; Wang QS; Saiki R; Ishihara R; Matsubara Y; Hamamoto J; Hayashi H; Yoshimura Y; Tachikawa N; Yanagita E; Hyugaji T; Shimizu E; Katayama K; Kato Y; Morita T; Takahashi K; Harada N; Naito T; Hiki M; Matsushita Y; Takagi H; Aoki R; Nakamura A; Harada S; Sasano H; Kabata H; Masaki K; Kamata H; Ikemura S; Chubachi S; Okamori S; Terai H; Morita A; Asakura T; Sasaki J; Morisaki H; Uwamino Y; Nanki K; Uchida S; Uno S; Nishimura T; Ishiguro T; Isono T; Shibata S; Matsui Y; Hosoda C; Takano K; Nishida T; Kobayashi Y; Takaku Y; Takayanagi N; Ueda S; Tada A; Miyawaki M; Yamamoto M; Yoshida E; Hayashi R; Nagasaka T; Arai S; Kaneko Y; Sasaki K; Tagaya E; Kawana M; Arimura K; Takahashi K; Anzai T; Ito S; Endo A; Uchimura Y; Miyazaki Y; Honda T; Tateishi T; Tohda S; Ichimura N; Sonobe K; Sassa CT; Nakajima J; Nakano Y; Nakajima Y; Anan R; Arai R; Kurihara Y; Harada Y; Nishio K; Ueda T; Azuma M; Saito R; Sado T; Miyazaki Y; Sato R; Haruta Y; Nagasaki T; Yasui Y; Hasegawa Y; Mutoh Y; Kimura T; Sato T; Takei R; Hagimoto S; Noguchi Y; Yamano Y; Sasano H; Ota S; Nakamori Y; Yoshiya K; Saito F; Yoshihara T; Wada D; Iwamura H; Kanayama S; Maruyama S; Yoshiyama T; Ohta K; Kokuto H; Ogata H; Tanaka Y; Arakawa K; Shimoda M; Osawa T; Tateno H; Hase I; Yoshida S; Suzuki S; Kawada M; Horinouchi H; Saito F; Mitamura K; Hagihara M; Ochi J; Uchida T; Baba R; Arai D; Ogura T; Takahashi H; Hagiwara S; Nagao G; Konishi S; Nakachi I; Murakami K; Yamada M; Sugiura H; Sano H; Matsumoto S; Kimura N; Ono Y; Baba H; Suzuki Y; Nakayama S; Masuzawa K; Namba S; Suzuki K; Naito Y; Liu YC; Takuwa A; Sugihara F; Wing JB; Sakakibara S; Hizawa N; Shiroyama T; Miyawaki S; Kawamura Y; Nakayama A; Matsuo H; Maeda Y; Nii T; Noda Y; Niitsu T; Adachi Y; Enomoto T; Amiya S; Hara R; Yamaguchi Y; Murakami T; Kuge T; Matsumoto K; Yamamoto Y; Yamamoto M; Yoneda M; Kishikawa T; Yamada S; Kawabata S; Kijima N; Takagaki M; Sasa N; Ueno Y; Suzuki M; Takemoto N; Eguchi H; Fukusumi T; Imai T; Fukushima M; Kishima H; Inohara H; Tomono K; Kato K; Takahashi M; Matsuda F; Hirata H; Takeda Y; Koh H; Manabe T; Funatsu Y; Ito F; Fukui T; Shinozuka K; Kohashi S; Miyazaki M; Shoko T; Kojima M; Adachi T; Ishikawa M; Takahashi K; Inoue T; Hirano T; Kobayashi K; Takaoka H; Watanabe K; Miyazawa N; Kimura Y; Sado R; Sugimoto H; Kamiya A; Kuwahara N; Fujiwara A; Matsunaga T; Sato Y; Okada T; Hirai Y; Kawashima H; Narita A; Niwa K; Sekikawa Y; Nishi K; Nishitsuji M; Tani M; Suzuki J; Nakatsumi H; Ogura T; Kitamura H; Hagiwara E; Murohashi K; Okabayashi H; Mochimaru T; Nukaga S; Satomi R; Oyamada Y; Mori N; Baba T; Fukui Y; Odate M; Mashimo S; Makino Y; Yagi K; Hashiguchi M; Kagyo J; Shiomi T; Fuke S; Saito H; Tsuchida T; Fujitani S; Takita M; Morikawa D; Yoshida T; Izumo T; Inomata M; Kuse N; Awano N; Tone M; Ito A; Nakamura Y; Hoshino K; Maruyama J; Ishikura H; Takata T; Odani T; Amishima M; Hattori T; Shichinohe Y; Kagaya T; Kita T; Ohta K; Sakagami S; Koshida K; Hayashi K; Shimizu T; Kozu Y; Hiranuma H; Gon Y; Izumi N; Nagata K; Ueda K; Taki R; Hanada S; Kawamura K; Ichikado K; Nishiyama K; Muranaka H; Nakamura K; Hashimoto N; Wakahara K; Sakamoto K; Omote N; Ando A; Kodama N; Kaneyama Y; Maeda S; Kuraki T; Matsumoto T; Yokote K; Nakada TA; Abe R; Oshima T; Shimada T; Harada M; Takahashi T; Ono H; Sakurai T; Shibusawa T; Kimizuka Y; Kawana A; Sano T; Watanabe C; Suematsu R; Sageshima H; Yoshifuji A; Ito K; Takahashi S; Ishioka K; Nakamura M; Masuda M; Wakabayashi A; Watanabe H; Ueda S; Nishikawa M; Chihara Y; Takeuchi M; Onoi K; Shinozuka J; Sueyoshi A; Nagasaki Y; Okamoto M; Ishihara S; Shimo M; Tokunaga Y; Kusaka Y; Ohba T; Isogai S; Ogawa A; Inoue T; Fukuyama S; Eriguchi Y; Yonekawa A; Kan-O K; Matsumoto K; Kanaoka K; Ihara S; Komuta K; Inoue Y; Chiba S; Yamagata K; Hiramatsu Y; Kai H; Asano K; Oguma T; Ito Y; Hashimoto S; Yamasaki M; Kasamatsu Y; Komase Y; Hida N; Tsuburai T; Oyama B; Takada M; Kanda H; Kitagawa Y; Fukuta T; Miyake T; Yoshida S; Ogura S; Abe S; Kono Y; Togashi Y; Takoi H; Kikuchi R; Ogawa S; Ogata T; Ishihara S; Kanehiro A; Ozaki S; Fuchimoto Y; Wada S; Fujimoto N; Nishiyama K; Terashima M; Beppu S; Yoshida K; Narumoto O; Nagai H; Ooshima N; Motegi M; Umeda A; Miyagawa K; Shimada H; Endo M; Ohira Y; Watanabe M; Inoue S; Igarashi A; Sato M; Sagara H; Tanaka A; Ohta S; Kimura T; Shibata Y; Tanino Y; Nikaido T; Minemura H; Sato Y; Yamada Y; Hashino T; Shinoki M; Iwagoe H; Takahashi H; Fujii K; Kishi H; Kanai M; Imamura T; Yamashita T; Yatomi M; Maeno T; Hayashi S; Takahashi M; Kuramochi M; Kamimaki I; Tominaga Y; Ishii T; Utsugi M; Ono A; Tanaka T; Kashiwada T; Fujita K; Saito Y; Seike M; Watanabe H; Matsuse H; Kodaka N; Nakano C; Oshio T; Hirouchi T; Makino S; Egi M; ; Omae Y; Nannya Y; Ueno T; Katayama K; Ai M; Fukui Y; Kumanogoh A; Sato T; Hasegawa N; Tokunaga K; Ishii M; Koike R; Kitagawa Y; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K; Okada Y
Nature; 2022 Sep; 609(7928):754-760. PubMed ID: 35940203
[TBL] [Abstract][Full Text] [Related]
2. DOCK2 contributes to endotoxemia-induced acute lung injury in mice by activating proinflammatory macrophages.
Xu X; Su Y; Wu K; Pan F; Wang A
Biochem Pharmacol; 2021 Feb; 184():114399. PubMed ID: 33382969
[TBL] [Abstract][Full Text] [Related]
3. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
[TBL] [Abstract][Full Text] [Related]
4. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
5. Dedicator of cytokinesis protein 2 couples with lymphoid enhancer-binding factor 1 to regulate expression of CD21 and B-cell differentiation.
Jing Y; Kang D; Liu L; Huang H; Chen A; Yang L; Jiang P; Li N; Miller H; Liu Z; Zhu X; Yang J; Wang X; Sun J; Liu Z; Liu W; Zhou X; Liu C
J Allergy Clin Immunol; 2019 Nov; 144(5):1377-1390.e4. PubMed ID: 31405607
[TBL] [Abstract][Full Text] [Related]
6. DOCK2 and DOCK5 act additively in neutrophils to regulate chemotaxis, superoxide production, and extracellular trap formation.
Watanabe M; Terasawa M; Miyano K; Yanagihara T; Uruno T; Sanematsu F; Nishikimi A; Côté JF; Sumimoto H; Fukui Y
J Immunol; 2014 Dec; 193(11):5660-7. PubMed ID: 25339677
[TBL] [Abstract][Full Text] [Related]
7. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
Ma Y; Qiu F; Deng C; Li J; Huang Y; Wu Z; Zhou Y; Zhang Y; Xiong Y; Yao Y; Zhong Y; Qu J; Su J
Genome Med; 2022 Feb; 14(1):16. PubMed ID: 35172892
[TBL] [Abstract][Full Text] [Related]
8. Dedicator of Cytokinesis 2 (DOCK2) Silencing Protects Against Cerebral Ischemia/Reperfusion by Modulating Microglia Polarization via the Activation of the STAT6 Signaling Pathway.
Ding S; Cao Y; Lu X; Zhang H; Cong L; Yi T; Xu M; Wang L
Neuroscience; 2022 May; 491():110-121. PubMed ID: 35395356
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
[TBL] [Abstract][Full Text] [Related]
10. The role of Dock2 on macrophage migration and functions during Citrobacter rodentium infection.
Ji L; Chen Y; Xie L; Liu Z
Clin Exp Immunol; 2021 Jun; 204(3):361-372. PubMed ID: 33662140
[TBL] [Abstract][Full Text] [Related]
11. DOCK2 couples with LEF-1 to regulate B cell metabolism and memory response.
Yang L; Jing Y; Wang W; Ying W; Lin L; Chang J; Luo L; Kang D; Jiang P; Liu J; Chen Q; Miller H; Herrada AA; Kubo M; Sun J; Liu C
Biochem Biophys Res Commun; 2020 Aug; 529(2):296-302. PubMed ID: 32703426
[TBL] [Abstract][Full Text] [Related]
12. Dedicator of Cytokinesis 2 (DOCK2) Deficiency Attenuates Lung Injury Associated with Chronic High-Fat and High-Fructose Diet-Induced Obesity.
Qian G; Adeyanju O; Sunil C; Huang SK; Chen SY; Tucker TA; Idell S; Guo X
Am J Pathol; 2022 Feb; 192(2):226-238. PubMed ID: 34767813
[TBL] [Abstract][Full Text] [Related]
13. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
14. miR-16 exhibits protective function in LPS-treated cardiomyocytes by targeting DOCK2 to repress cell apoptosis and exert anti-inflammatory effect.
Wang L; Zhang Y; Zhu G; Ma Y; Zuo H; Tian X
Cell Biol Int; 2020 Aug; 44(8):1760-1768. PubMed ID: 32369253
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses.
Purtha WE; Swiecki M; Colonna M; Diamond MS; Bhattacharya D
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):E898-904. PubMed ID: 22431588
[TBL] [Abstract][Full Text] [Related]
16. Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.
Yasuda K; Nündel K; Watkins AA; Dhawan T; Bonegio RG; Ubellacker JM; Marshak-Rothstein A; Rifkin IR
Int Immunol; 2013 May; 25(5):295-306. PubMed ID: 23291967
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol sulfate is a DOCK2 inhibitor that mediates tissue-specific immune evasion in the eye.
Sakurai T; Uruno T; Sugiura Y; Tatsuguchi T; Yamamura K; Ushijima M; Hattori Y; Kukimoto-Niino M; Mishima-Tsumagari C; Watanabe M; Suematsu M; Fukui Y
Sci Signal; 2018 Jul; 11(541):. PubMed ID: 30065028
[TBL] [Abstract][Full Text] [Related]
18. FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways.
Wu M; Li L; Hamaker M; Small D; Duffield AS
Haematologica; 2019 Dec; 104(12):2418-2428. PubMed ID: 30975911
[TBL] [Abstract][Full Text] [Related]
19. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR
PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492
[TBL] [Abstract][Full Text] [Related]
20. Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2.
Nishikimi A; Uruno T; Duan X; Cao Q; Okamura Y; Saitoh T; Saito N; Sakaoka S; Du Y; Suenaga A; Kukimoto-Niino M; Miyano K; Gotoh K; Okabe T; Sanematsu F; Tanaka Y; Sumimoto H; Honma T; Yokoyama S; Nagano T; Kohda D; Kanai M; Fukui Y
Chem Biol; 2012 Apr; 19(4):488-97. PubMed ID: 22520755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
